Health · Medical Research · 1 hr ago

Once-daily pill lowered LDL cholesterol by nearly 65% in a trial

Once-daily pill lowered LDL cholesterol by nearly 65% in a trial

Enlicitide lowered LDL cholesterol by nearly 65% in a trial of adults who were already taking statins.

The once-daily pill, also called Lipfendra, is approved by the US Food and Drug Administration.

It is the first oral drug in a class of PCSK9 treatments that was previously available only as injections.

LDL cholesterol can build up in artery walls and raise the risk of heart attacks and strokes, while some people need more treatment than statins provide.

The pill works by blocking a protein so the liver can remove more LDL cholesterol from the blood.

Trials found side effects were generally similar to placebo, though one study of people with inherited high cholesterol reported more diarrhea and dizziness.

Patients must take it in the morning on an empty stomach and wait at least 30 minutes before eating.

A trial is still testing whether it prevents heart attacks and strokes, and longer-term monitoring will help establish its safety.

1 source

Related